Skip to main content
. 2011 Jun 27;6(6):e21455. doi: 10.1371/journal.pone.0021455

Figure 2. Analysis of human serum and affinity chromatography fractions, FE and FG by dot blotting using anti-human biotin IgE/streptavidin-biotinylated-HRP.

Figure 2

A1) negative control: buffer plus human (patient 3) total serum; A2) 2S albumin plus human (patient 3) total serum; A3) 2S albumin incubated with affinity chromatography fraction, FE; A4) 2S albumin incubated with affinity chromatography fraction, FG.